Table 1.
Patient Demographics and Clinical Data.
| Character | Sodium chloride | Sodium gluconate | p (Fisher exact probability test) |
|---|---|---|---|
| Sample size, n | 25 | 25 | |
| Age (years), mean ± SD | 38.37 ± 8.58 | 39.25 ± 7.23 | |
| Days since symptoms to enrollment, mean ± SD | 95.23 ± 6.24 | 97.37 ± 5.89 | |
| Gender (male/female), n | 9/16 | 10/15 | |
| Smokers (current/never), n | 3/22 | 5/20 | 0.70 |
| Comorbidities, n | |||
| Asthma | 2 | 3 | 1.00 |
| Diabetes | 7 | 8 | 1.00 |
| Hypertension | 5 | 3 | 0.70 |
| Migraine | 0 | 1 | 1.00 |
| Sinusitis | 7 | 8 | 1.00 |
| Current medication | Antihistamine Metformin B-blocker ACE inhibitor Paracetamol |
Antihistamine Glipizide Amlodipine ACE inhibitor Paracetamol |
|
| Previous anosmia treatment | None (n = 10) Topical steroids (n = 10) Systemic + topical steroids (n = 5) |
None (n = 8) Topical steroids (n = 9) Systemic + topical steroids (n = 5) Vitamin A (n = 3) |
Abbreviations: SD, standard deviation: ACE, angiotensin-converting enzyme.